PSYCH Symposium 2025

PSYCH Symposium 2025 will be held in London at Conway Hall on December 4th, 2025. After two sold-out editions in 2022 and 2023, PSYCH Symposium has become an important European gathering for thought leaders in the emerging field of psychedelic medicine; one of the fastest-growing and most promising fields in mental health.

The 2025 edition of PSYCH Symposium is a collaboration between Prohibition Partners and Drug Science. The two organisations collectively bring forward decades of expertise as trusted platforms for discussing policy, science, and investment in the emerging field of psychedelic medicine.

The event will bring together clinicians, researchers, policymakers, investors, and patient advocates to discuss:

The latest clinical findings on psilocybin, MDMA, ketamine, and other emerging compounds

The business and investment landscape for psychedelic medicines

Policy frameworks and regulatory updates across Europe and globally

Ethical considerations and patient safety in psychedelic-assisted therapies

The latest clinical findings on psilocybin, MDMA, ketamine, and other emerging compounds

The business and investment landscape for psychedelic medicines

Policy frameworks and regulatory updates across Europe and globally

Ethical considerations and patient safety in psychedelic-assisted therapies

PSYCH Symposium 2025 will spotlight new data, clinical delivery models, and equitable access strategies. Attendees can expect high-quality networking opportunities, in-depth discussions, and a focused environment conducive to meaningful collaboration among key stakeholders in the psychedelic medicine ecosystem.